What is PancreaDix®?

PancreaDix® is an innovative, non-invasive signature in blood for:

  • Confirming a Pancreatic cancer diagnosis
  • Detecting pre-malignant lesions that will evolve to cancer
  • Performing a differential diagnosis between Pancreatic cancer and other pathologies such as chronic pancreatitis or neuroendocrine tumors.

How does it work?

A diagnostics revolution. Helping to protect.

PancreaDix® identifies and measures biomarkers which are differentially expressed in blood samples of individuals with Pancreatic Cancer (PaC)

PancreaDix® characteristics

Learn more about PancreaDix®

PancreaDix® will typically be prescribed by the Gastroenterologist or the General Practitioner to patients with:
  • Incidental findings in the pancreas
  • Symptoms compatible with pancreatic cancer.
  • Case of chronic pancreatitis or neuroendocrine tumors to confirm that it is not cancer.
  • Case of cysts to diagnose their potential malignancy to proceed with surgery or not.
  • Inconclusive biopsies or images.
  • High-risk for Pancreatic Cancer, recommended for screening (this group of patients should be included in future studies).
PancreaDix® will improve the early detection of premalignant and malignant lesions of pancreatic cancer and it enables physicians to better manage patients with pancreatic cancer and other pancreatic pathologies.
There are no national or international screening programs for pancreatic cancer. PancreaDix® would also serve as a screening tool for an eligible high-risk population due to hereditary risk or long-standing diabetes.

We are conducting a national clinical study to further validate this technology.

If you want more details, please contact us.


Intellectual Property Protection

Protecting value through our Intellectual Property

The PancreaDix® patent is protected in main markets.


All about Cancer

Pancreatic Cancer

Pancreatic cancer (also known as PaC) begins in the tissues of the pancreas, an organ in the abdomen that lies behind the lower part of the stomach. The pancreas releases enzymes that aid digestion and produces hormones that help control blood glucose. Pancreatic cancer is one of the more aggressive neoplasms and has a worse prognosis due to its early dissemination, lack of specific symptoms in early stages and, therefore, a late diagnosis.
Early detection, understood as a diagnosis of the disease in operable stages, is therefore essential to improve patient survival (…)

Personalized and precision medicine

Personalized medicine, or precision medicine, is a healthcare approach in which a patient’s information, such as molecular information (genomic, transcriptomic, proteomic, metabolomic, etc.), phenotypic characteristics, and health data are used to prevent, diagnose, or treat human disease, thereby resulting in improved health outcomes.
Personalized medicine represents an important improvement and evolution from traditional practices in healthcare (…)


In medicine, prevention is the measures taken to reduce the chances of developing an illness, like getting vaccinated. In cancer, prevention is the best way to reduce the chances of having cancer, and if you have it, it is the best way to detect it in its early stages, thus leading to a higher survival rate.
There are different levels of prevention (…)

Let’s extend
people’s lives

Come and join us to Detect cancer in blood.

Open chat
Hello 👋
How can we assist you today?